New targeted combination in people with relapsed acute myeloid leukemia shows promise
New research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational treatment approach using the targeted therapy ziftomenib for patients with a difficult-to-treat form ...
22 hours ago
0
2









